Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis
- PMID: 26170735
- PMCID: PMC4499643
- DOI: 10.4196/kjpp.2015.19.4.319
Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis
Abstract
Among solute carrier proteins, the organic anion transporters (OATs) play an important role for the elimination or reabsorption of endogenous and exogenous negatively charged anionic compounds. Among OATs, SLC22A9 (hOAT7) transports estrone sulfate with high affinity. The net decrease of estrogen, especially in post-menopausal women induces rapid bone loss. The present study was performed to search the SNP within exon regions of SLC22A9 in Korean females with osteoporosis. Fifty healthy controls and 50 osteoporosis patients were screened for the genetic polymorphism in the coding region of SLC22A9 using GC-clamped PCR and denaturing gradient gel electrophoresis (DGGE). Six SNPs were found on the SLC22A9 gene from Korean women with/without osteoporosis. The SNPs were located as follows: two SNPs in the osteoporosis group (A645G and T1277C), three SNPs in the control group (G1449T, C1467T and C1487T) and one SNP in both the osteoporosis and control groups (G767A). The G767A, T1277C and C1487T SNPs result in an amino acid substitution, from synonymous vs nonsynonymous substitution arginine to glutamine (R256Q), phenylalanine to serine (F426S) and proline to leucine (P496L), respectively. The Km values and Vmax of the wild type, R256Q, P496L and F426S were 8.84, 8.87, 9.83 and 12.74 µM, and 1.97, 1.96, 2.06 and 1.55 pmol/oocyte/h, respectively. The present study demonstrates that the SLC22A9 variant F426S is causing inter-individual variation that is leading to the differences in transport of the steroid sulfate conjugate (estrone sulfate) and, therefore this could be used as a marker for certain disease including osteoporosis.
Keywords: Denaturing gradient gel electrophoresis; Estrone sulfate; GC-clamp; Osteoporosis; Polymorphism; SLC22A9.
Figures



Similar articles
-
The Membrane Transporter OAT7 (SLC22A9) Is Not a Susceptibility Factor for Osteoporosis in Europeans.Front Endocrinol (Lausanne). 2020 Aug 18;11:532. doi: 10.3389/fendo.2020.00532. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33013684 Free PMC article.
-
Identification and characterization of single nucleotide polymorphisms of SLC22A11 (hOAT4) in Korean women osteoporosis patients.Mol Cells. 2008 Apr 30;25(2):265-71. Epub 2008 Mar 31. Mol Cells. 2008. PMID: 18414001
-
Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].Kidney Int. 2005 Oct;68(4):1491-9. doi: 10.1111/j.1523-1755.2005.00612.x. Kidney Int. 2005. PMID: 16164626
-
Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate.Hepatology. 2007 Apr;45(4):1046-55. doi: 10.1002/hep.21596. Hepatology. 2007. PMID: 17393504
-
In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.Handb Exp Pharmacol. 2011;(201):29-104. doi: 10.1007/978-3-642-14541-4_2. Handb Exp Pharmacol. 2011. PMID: 21103968 Review.
Cited by
-
The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates.Front Pharmacol. 2022 Jan 13;12:802539. doi: 10.3389/fphar.2021.802539. eCollection 2021. Front Pharmacol. 2022. PMID: 35095509 Free PMC article. Review.
-
GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes.Oncotarget. 2018 Jul 3;9(51):29789-29800. doi: 10.18632/oncotarget.25712. eCollection 2018 Jul 3. Oncotarget. 2018. PMID: 30038720 Free PMC article.
-
The Membrane Transporter OAT7 (SLC22A9) Is Not a Susceptibility Factor for Osteoporosis in Europeans.Front Endocrinol (Lausanne). 2020 Aug 18;11:532. doi: 10.3389/fendo.2020.00532. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33013684 Free PMC article.
References
-
- Riggs BL, Khosla S, Melton LJ., 3rd Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23:279–302. - PubMed
-
- Bonjour JP, Theintz G, Law F, Slosman D, Rizzoli R. Peak bone mass: facts and uncertainties. Arch Pediatr. 1995;2:460–468. - PubMed
-
- Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337–342. - PubMed
-
- Wang FS, Ko JY, Lin CL, Wu HL, Ke HJ, Tai PJ. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats. Bone. 2007;40:485–492. - PubMed
-
- Muir M, Romalo G, Wolf L, Elger W, Schweikert HU. Estrone sulfate is a major source of local estrogen formation in human bone. J Clin Endocrinol Metab. 2004;89:4685–4692. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous